January 12, 2023 Citizens of Livingston Parish, vendors, and a representative from the American Kratom Association (AKA) gathered at a council meeting to discuss a proposed kratom ban ordinance. The portion of the meeting discussing kratom, which councilman Tracy Girlinghouse called a “fact-finding mission”, lasted about 45 minutes. The council took comments from those in …
A federal bill cosponsored by Corey Booker (D-NJ) and Mike Lee (R-UT) in the Senate and Mark Pocan (D-WI) in the House would compel Congress to begin the process of regulating kratom on a national level, and protect the kratom industry and consumers against current Food and Drug Administration (FDA) restrictions. The cosponsors introduced the …
In a study published in October in Frontiers in Plant Science, researchers collected leaves from kratom trees in various regions of Thailand to measure mitragynine (MG) levels, and to account for environmental variables that may influence the alkaloid content. The team from Kasetsart University in Bangkok found a range of mitragynine content, from 7.5 to …
Scientists study mitragynine levels in Thai kratom Read More »
Dr. Jon starts off talking about the art show that took place in October 2022 at the new Cannabis Museum in Athens Ohio. Then we cover a study out of Thailand on kratom’s effects on alpha-glucosidase and lipase, enzymes that are inhibited by medications for the treatment of diabetes. We see how kratom and mitragynine …
Journal Club #37: Kratom and Diabetes Study from Thailand Read More »
The conversation around kratom is as complex as the plant itself. For kratom to manifest in our society as a healing plant instead of a perceived dangerous drug, the science of kratom needs to become conventional wisdom. For the millions of Americans kratom has already helped, we can’t afford to spend 80 years digging our …
Why engaging with kratom misinformation hurts more than helps Read More »
A Vancouver drug company announced that it has filed a patent for a deuterated form of 7-hydroxymitragynine (7-HMG) called D7-h. The company, Nirvana Life Sciences Inc., intends to pursue D7-h as a pain relieving drug, citing 7-HMG’s partial opioid agonism, and the deuteration process that they say makes the drug last longer. A deuterated drug …
Is it a good idea to make a 7-hydroxymitragynine based drug? Read More »
Kailee joins Brian to look at the latest kratom news. This month we look at an investigative report asking questions about academic freedom at University of Florida that directly affected kratom scientists, past podcast guest Oliver Grundmann and Christopher McCurdy. Kratom regulations preventing sales to minors pass Pennsylvania House. A kratom consumer protection act is …
The audio version of this interview can be found as episode 30 of the Kratom Science Podcast. References to studies discussed are also listed there. Dr. Darshan Singh from the Center for Drug Research at the University of Science in Malaysia. Dr. Singh studies substance abuse, addiction treatment, and harm reduction. He has conducted multiple …
QR Code link https://enroll.drugabuse.gov/kratom-nida/ From the research team: About The KEMA Study We are conducting a new study on kratom entitled “Real-world momentary assessment of kratom use accompanied by product assays: A natural history study toward an interdisciplinary characterization of kratom use and pharmacology”! That is a long name, so we typically refer to it …
NIDA is rolling out a massive nationwide study of regular kratom consumers Read More »
Kailee joins Brian to discuss the latest in kratom legal, international, and science news for July 2022. Articles discussed in this episode: PA House passes bill banning sale of Kratom to minors https://www.wkbn.com/news/pennsylvania/pa-house-passes-bill-banning-sale-of-kratom-to-minors/ Online kratom sales okayed by [Thailand’s] House https://www.bangkokpost.com/thailand/general/2337463/online-kratom-sales-okayed-by-house Buddhist monks banned from using cannabis, except as medicine https://www.nationmultimedia.com/in-focus/40017260 “Kratom use as more …
